Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456
Clinical trial NCT03282851 · COMPLETED
Trial details
- NCT number
- NCT03282851
- Sponsor
- Fresenius Kabi SwissBioSim GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2019-10-01
- Enrollment
- 696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.